March 1, 2022 | Market Access, oncology
Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies
With CAR-Ts continuing to take centre stage as a paradigm shift in the treatment of cancer, Tania Rodrigues investigates how market access and hospital processes will need to transform to accommodate the influx of these innovative therapies.
Download the white paper here: https://bit.ly/36T8d5j
This content was provided by Inizio
Latest Content from Inizio
We are delighted to welcome Marianne Jaeger as Associate Director to our London headquarters
The need to understand the patient as a key stakeholder is now recognized by pharma across the globe.
Research Partnership has extended its healthcare research and consulting offering to include storytelling deliverables with the hire of multi-media graphic designer Amanda Brent at the company’s London headquarters. Working with…
The latest league tables for the UK market research industry have just been released and reveal Research Partnership to be the fastest growing healthcare market research specialist for 2014.With turnover…
Using our combined knowledge and years of experience of working in these territories, our experts have produced an essential guide to help address some of the core challenges for conducting market…
This white paper explores the global outlook for new immunotherapy products, referencing key opinion leaders and payers to investigate how these products are faring both clinically and financially. Immuno-oncology therapies that…
Published in Medical Marketing & Media November 2015
Using in-depth-interviews to determine how to maximise the commercial opportunities in different emerging markets
Published in eyeforpharma 16 November by Rachel Howard
Our latest case study demonstrates how a mobile app methodology was used to deliver key insights into issues faced by COPD patients
